317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors by Leisha Emens, Naomi Hunder, Samuel Klempner, Erika Hamilton, Muralidhar Beeram, Valerie Odegard, Sue Hamke

708 A phase 1/2 study of rinatabart sesutecan (PRO1184), a novel folate receptor alpha-directed antibody-drug conjugate, in patients with locally advanced and/or metastatic solid t... by Jing Wang, Jian Zhang, Jun Zhang, Ning Li, Xiaohua Wu, Elizabeth Lee, Naomi Hunder, Ying Cheng, Debra L Richardson, Erika Hamilton, Lin Wu, Ira Winer, Ian Anderson, Gottfried Konecny, Douglas Orr, Oladapo Yeku, Sandip P Patel, Sharon Ma, Eric Song, Justin A Call, Lian Lu

718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies by Li Zhang, Ning Li, Brendan Curti, Stephen Spurgeon, Elisabeth Heath, Naomi Hunder, Eric Jonasch, Dingwei Ye, Zhu Chen, Melissa Reimers, Stephen Park, Weidong Li, Paolo Caimi, Ulka N Vaishampayan, Benjamin Garmezy, Swetha Kambhampati, Catherine Diefenbach, Noah Kornblum, Weili Zhao, Sharon Ma, Eric Song, Justin A Call